Orion Oyj A - Asset Resilience Ratio

Latest as of June 2025: 11.16%

Orion Oyj A (ORNAV) has an Asset Resilience Ratio of 11.16% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ORNAV liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

€183.60 Million

≈ $214.65 Million USD Cash + Short-term Investments

Total Assets

€1.65 Billion

≈ $1.92 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2022)

This chart shows how Orion Oyj A's Asset Resilience Ratio has changed over time. See ORNAV total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Orion Oyj A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ORNAV stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€183.60 Million	11.16%
Short-term Investments	€0.00	0%
Total Liquid Assets	€183.60 Million	11.16%

Asset Resilience Insights

Moderate Liquidity: Orion Oyj A has 11.16% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Orion Oyj A Industry Peers by Asset Resilience Ratio

Compare Orion Oyj A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AstraZeneca PLC NASDAQ:AZN	Drug Manufacturers - General	5.03%
Novartis AG MX:NVSN	Drug Manufacturers - General	0.09%
Novartis AG ADR NYSE:NVS	Drug Manufacturers - General	10.03%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	7.18%
Virbac SA PA:VIRP	Drug Manufacturers - General	0.23%
Yifan Xinfu Pharmaceutical Co Ltd SHE:002019	Drug Manufacturers - General	0.53%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	8.63%

Annual Asset Resilience Ratio for Orion Oyj A (2010–2022)

The table below shows the annual Asset Resilience Ratio data for Orion Oyj A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	-0.07%	€-1.00 Million ≈ $-1.17 Million	€1.50 Billion ≈ $1.76 Billion	+1.32pp
2021-12-31	-1.38%	€-15.40 Million ≈ $-18.00 Million	€1.11 Billion ≈ $1.30 Billion	-1.34pp
2020-12-31	-0.04%	€-500.00K ≈ $-584.55K	€1.12 Billion ≈ $1.30 Billion	-3.42pp
2019-12-31	3.38%	€35.00 Million ≈ $40.92 Million	€1.04 Billion ≈ $1.21 Billion	+0.33pp
2018-12-31	3.05%	€35.00 Million ≈ $40.92 Million	€1.15 Billion ≈ $1.34 Billion	+8.46pp
2017-12-31	-5.41%	€-57.10 Million ≈ $-66.76 Million	€1.06 Billion ≈ $1.23 Billion	-8.33pp
2016-12-31	2.92%	€31.00 Million ≈ $36.24 Million	€1.06 Billion ≈ $1.24 Billion	+5.64pp
2015-12-31	-2.72%	€-28.50 Million ≈ $-33.32 Million	€1.05 Billion ≈ $1.22 Billion	-10.01pp
2014-12-31	7.29%	€73.00 Million ≈ $85.34 Million	€1.00 Billion ≈ $1.17 Billion	+10.13pp
2013-12-31	-2.84%	€-27.80 Million ≈ $-32.50 Million	€979.00 Million ≈ $1.14 Billion	+2.19pp
2011-12-31	-5.03%	€-39.20 Million ≈ $-45.83 Million	€779.10 Million ≈ $910.85 Million	-15.45pp
2010-12-31	10.42%	€77.70 Million ≈ $90.84 Million	€745.80 Million ≈ $871.92 Million	--

pp = percentage points

About Orion Oyj A

HE:ORNAV Finland Drug Manufacturers - General

Market Cap

$2.54 Billion

€2.17 Billion EUR

Market Cap Rank

#5448 Global

#23 in Finland

Share Price

€68.10

Change (1 day)

+3.03%

52-Week Range

€54.10 - €74.80

All Time High

€74.80